AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Follicular Lymphoma

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia NCT05281809Phase 21 site๐Ÿ“ Pittsburgh John Lister ยท Tests: Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous) Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Follicular Lymphoma in Real World Study NCT05846763n/a1 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma NCT07121946Phase 16 sites๐Ÿ“ Duarte๐Ÿ“ St Louis๐Ÿ“ Buffalo LTZ Therapeutics, Inc. ยท Tests: LTZ-301, LTZ-301, LTZ-301 Zanubrutinib, Obinutuzumab Combined With Lenalidomide (ZGR) for the Treatment of Untreated Follicular Lymphoma NCT07299149Phase 22 sites๐Ÿ“ Tianjin๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Induction Therapy: Zanubrutinib, obinutuzumab, lenalidomide, Maintenance therapy: Zanubrutinib, lenalidomide 5HTP Regulation Of Asthma In Children NCT04160910Phase 21 site๐Ÿ“ Indianapolis Indiana University ยท Tests: 5-Hydroxytryptophan, Placebo Ovarian Hyperstimulation Syndrome Prevention NCT06739759NA2 sites๐Ÿ“ Giza๐Ÿ“ Giza Aljazeera Hospital ยท Tests: Antagonist protocol for IVF, Modified Agonist protocol for IVF with additive treatments as HCQ A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234 NCT07546760Phase 14 sites๐Ÿ“ Chandler๐Ÿ“ Rialto๐Ÿ“ Miami Lakes AstraZeneca ยท Tests: AZD6234, AZD9550 SynKIR-310 for Relapsed/Refractory B-NHL NCT06544265Phase 15 sites๐Ÿ“ Denver๐Ÿ“ Atlanta๐Ÿ“ Fairway Verismo Therapeutics ยท Tests: SynKIR-310 Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody NCT05045664Phase 312 sites๐Ÿ“ Berlin๐Ÿ“ Essen๐Ÿ“ Gรถttingen Heidelberg University ยท Tests: Standard, Experimental, Standard, Experimental R-CDOP Regimen in the Treatment of Newly Diagnosed Non-Hodgkin's Lymphoma With High Tumor Burden NCT05040555NA1 site๐Ÿ“ Changchun oubai, MD/PhD ยท Tests: R-CDOP Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma NCT04792502Phase 23 sites๐Ÿ“ New Haven๐Ÿ“ New Brunswick๐Ÿ“ Providence Brown University ยท Tests: Mosunetuzumab, Lenalidomide A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma NCT03460977Phase 185 sites๐Ÿ“ Tucson๐Ÿ“ Tucson๐Ÿ“ Tucson Pfizer ยท Tests: Mevrometostat (PF-06821497), Enzalutamide, Itraconazole Intracranial Genetically Modified Immune Cells (TGFฮฒR2KO/IL13Rฮฑ2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma NCT06815029Phase 11 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Biospecimen Collection, Chimeric Antigen Receptor T-Cell Therapy, Echocardiography, Fludeoxyglucose F-18, Intracranial โ€ฆ Q702 for the Treatment of Patients With Hematologic Malignancies NCT06712810Phase 12 sites๐Ÿ“ Scottsdale๐Ÿ“ Rochester Mayo Clinic ยท Tests: Axl/Mer/CSF1R Inhibitor Q702, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial NCT06948786Phase 21 site๐Ÿ“ Seattle University of Washington ยท Tests: Pirtobrutinib, Mosunetuzumab, Biospecimen Collection, Biopsy Procedure, Computed Tomography Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas NCT04883437Phase 21 site๐Ÿ“ Atlanta Emory University ยท Tests: Acalabrutinib, Obinutuzumab, Quality-of-Life Assessment, Questionnaire Administration Allo HSCT Using RIC and PTCy for Hematological Diseases NCT05805605Phase 21 site๐Ÿ“ Minneapolis Masonic Cancer Center, University of Minnesota ยท Tests: Peripheral Blood Stem Cell Transplant, Allopurinol 300 MG, Fludarabine, Cyclophosphamide, Bone Marrow Cell Transplant PMCF Study Fortilink-TS Ti NCT07834736n/a2 sites๐Ÿ“ Madrid๐Ÿ“ Oviedo BAAT Medical Products B.V. ยท Tests: Posterior lumbar interbody fusion surgery Long-term Follow up Local Registry Study of Kymriah in South Korea NCT06785818n/a18 sites๐Ÿ“ Bundang Gu๐Ÿ“ Seongnam-si๐Ÿ“ Gyeonggi-do Novartis Pharmaceuticals ยท Tests: Tisagenlecleucel Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma NCT05077527Phase 17 sites๐Ÿ“ Duarte๐Ÿ“ Chicago๐Ÿ“ New York AIDS Malignancy Consortium ยท Tests: Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine Combination of Zanubrutinib, Rituximab and Venetoclax in Patients With Previously Untreated Follicular Lymphoma NCT06471738Phase 21 site๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: Zanubrutinib, Rituximab, Venetoclax A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. NCT06022029Phase 116 sites๐Ÿ“ Los Angeles๐Ÿ“ Tamarac๐Ÿ“ Canton OncoNano Medicine, Inc. ยท Tests: ONM-501, Cemiplimab Drinking, Acetate, and Stress NCT06584448NA2 sites๐Ÿ“ New Haven๐Ÿ“ New Haven Yale University ยท Tests: Deuterium Metabolic Imaging with deuterated acetate tracer Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T NCT06784726Phase 21 site๐Ÿ“ Seattle University of Washington ยท Tests: Odronextamab, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Chimeric Antigen Receptor T-Cell Therโ€ฆ STimulation to Activate RespIration NCT06832306NA7 sites๐Ÿ“ La Jolla๐Ÿ“ Shreveport๐Ÿ“ Winston-Salem Lungpacer Medical Inc. ยท Tests: Phrenic Nerve Stimulation The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies NCT04329728Phase 1, Phase 211 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles AVM Biotechnology Inc ยท Tests: AVM0703 Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer NCT07215910Phase 3152 sites๐Ÿ“ Bakersfield๐Ÿ“ Duarte๐Ÿ“ Dublin Alliance for Clinical Trials in Oncology ยท Tests: Intensity-Modulated Radiation Therapy, Volume Modulated Arc Therapy, Pencil Beam Scanning, Intensity-Modulated Proton Tโ€ฆ Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses NCT07631598NA8 sites๐Ÿ“ Los Angeles๐Ÿ“ Washington D.C.๐Ÿ“ Baton Rouge Montefiore Medical Center ยท Tests: Standard of Care Referral, Low Threshold Buprenorphine Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas NCT07468136Phase 1, Phase 21 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Biospecimen Collection, Eflornithine, Lumbar Puncture, Magnetic Resonance Imaging, Retifanlimab Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) NCT07197307Phase 234 sites๐Ÿ“ Aachen๐Ÿ“ Augsburg๐Ÿ“ Berlin Universitรคt Mรผnster ยท Tests: Loncastuximab Tesirine and Epcoritamab
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy